Skip to content

Arrow Jugular Puncture Kit 16 Ga.

by Arrow Intl., Inc.

510(k) K820009

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK820009 Date22 Jan 1982ClearedStatusActive

Recalls

11 recalls · 1 ongoing · FDA

    • Ongoing Z-2377-2026 FDA Class I initiated 21 Apr 2026

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

    • Terminated Z-1243-2020 FDA Class II initiated 20 Dec 2019

    Product lidstock contains the incorrect expiration date for the product

    • Terminated Z-1974-2018 FDA Class II initiated 11 Apr 2018

    Product sterility may be compromised due to unsealed packaging.

    • Terminated Z-1331-2018 FDA Class II initiated 22 Dec 2017

    Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.

    • Terminated Z-2328-2017 FDA Class II initiated 9 May 2017

    Arrow International is recalling the affected product because the packaging may not be completely sealed, which may compromise sterility.

  • 5 recalls, same reason

    • Terminated Z-1349-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1347-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1345-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1344-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1348-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010

    Sterility may be compromised.

    • Terminated Z-1494-2009 FDA Unclassified (pre-2012) initiated 11 Feb 2009

    Leakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQY
Device Class
Class II
Regulation
21 CFR Part 870.1250
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arrow Jugular Puncture Kit 16 Ga. is a medical device designed for percutaneous access to the jugular vein. It is classified under product code DQY and was determined to be substantially equivalent to a predicate device through the FDA 510(k) process.

The device received FDA 510(k) clearance under number K820009 on January 22, 1982, following a traditional review by the Cardiovascular advisory committee. It is manufactured by Arrow Intl., Inc. and is supplied as a kit for clinical use in vascular access procedures.

Other devices from Arrow Intl., Inc.

See all devices from Arrow Intl., Inc. →

Questions

AI-generated answers, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Arrow Jugular Puncture Kit 16 Ga. used for?

    The Arrow Jugular Puncture Kit 16 Ga. is designed for percutaneous access to the jugular vein, enabling clinicians to perform vascular access procedures by introducing a needle or catheter through the skin into the vein.

  • How is the Arrow Jugular Puncture Kit 16 Ga. supplied?

    The device is supplied as a complete kit for clinical use, containing the necessary components for percutaneous jugular vein access, though specific kit contents are not detailed in the provided data.

  • What regulatory pathway was used for the Arrow Jugular Puncture Kit 16 Ga.?

    The Arrow Jugular Puncture Kit 16 Ga. received FDA 510(k) clearance under number K820009 on January 22, 1982, following a traditional review process, which determined it to be substantially equivalent to a predicate device.